Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 83.490 | 150.840 | 67.350 |
Bonds | 28.450 | 28.450 | 0.000 |
Other | 0.470 | 0.470 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.865 | 16.162 |
Price to Book | 2.171 | 2.326 |
Price to Sales | 1.335 | 1.678 |
Price to Cash Flow | 8.169 | 9.547 |
Dividend Yield | 2.383 | 2.502 |
5 Years Earnings Growth | 14.383 | 11.187 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 20.830 | 12.461 |
Consumer Cyclical | 18.730 | 12.154 |
Consumer Defensive | 17.330 | 7.949 |
Industrials | 14.410 | 12.265 |
Technology | 8.790 | 19.373 |
Energy | 5.100 | 4.661 |
Utilities | 4.610 | 3.510 |
Communication Services | 4.200 | 7.084 |
Financial Services | 3.130 | 15.106 |
Basic Materials | 2.800 | 7.124 |
Real Estate | 0.070 | 2.566 |
Number of long holdings: 117
Number of short holdings: 51
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Adidas | DE000A1EWWW0 | 5.81 | 231.50 | 0.00% | |
SalMar | NO0010310956 | 5.63 | 638.50 | +1.51% | |
Equity Swap es DOLLAR GENERAL CORP Morgan Stanley | - | 5.14 | - | - | |
Equity Swap JD SPORTS FASHION PLC | - | 5.11 | - | - | |
Novo Nordisk ADR | US6701002056 | 4.79 | 135.30 | +1.88% | |
TotalEnergies SE | FR0000120271 | 4.71 | 67.01 | +2.60% | |
EssilorLuxottica | FR0000121667 | 4.68 | 205.30 | +0.39% | |
Equity Swap KLA CORP | - | 4.56 | - | - | |
Pandora | DK0060252690 | 4.45 | 1,124.0 | +0.81% | |
Adyen | NL0012969182 | 4.42 | 1,184.80 | -0.65% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Varenne Selection A EUR | 264.18M | -6.10 | -1.61 | 8.80 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review